EXAMINATION OF EFFECTIVENESS OF OLOPATADINE HYDROCHLORIDE IN ATOPIC DERMATITIS

  • Shimizu Tadamichi
    Department of Dermatology, Hokkaido University Graduate School of Medicine
  • Mashiko Maki
    Department of Dermatology, Hokkaido University Graduate School of Medicine
  • Shimizu Hiroshi
    Department of Dermatology, Hokkaido University Graduate School of Medicine

Bibliographic Information

Other Title
  • アトピー性皮膚炎に対する塩酸オロパタジンの有効性の検討
  • アトピーセイ ヒフエン ニ タイスル エンサン オロパタジン ノ ユウコウセイ ノ ケントウ

Search this article

Description

Subjective/objective symptoms (itching, papula, erythema, lichenification, desquamation, scratching, erosion) and the levels of IgE, LDH, interleukin (IL)-6, thymus and activation-regulated chemokine (TARC) were compared before and after administering olopatadine hydrochloride (ALLELOCK(R) tablets) to 17 atopic dermatitis (AD) patients. Subject/objective symptoms improved significantly after administering the agent, and the total dosage of the combined topical steroids was also significantly decreased after administration (p<0.05), although IgE, IL-6 and LDH levels did not change. TARC was significantly decreased (p<0.05). The correlation between the levels of IgE, IL-6, LDH and TARC before and after the administration was examined. There was a positive correlation between IgE and TARC (r=0.62, p<0.01) and between IL-6 and TARC (r=0.78, p<0.01). Olopatadine hydrochloride is therefore useful in improving the symptoms in AD, and TARC may be used as an indicator of the symptom improvement.

Journal

Citations (1)*help

See more

References(17)*help

See more

Details 詳細情報について

Report a problem

Back to top